Verily And iRhythm Agree To Collaborate On Atrial Fibrillation

Posted by iRhythm Technologies on September 9, 2019

Executive Summary

Verily Life Sciences and iRhythm Technologies have agreed to co-develop technology for screening, diagnosing and managing patients with atrial fibrillation, combining iRhythm’s artificial intelligence system for diagnosing arrhythmias with Verily’s health data analytics technology.

This article was original published here.

Have a question?